This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Thomas Lilienkamp: Innovator in Myocardial Tissue Applications
Introduction
Thomas Lilienkamp is a notable inventor based in Göttingen, Germany. He has made significant contributions to the field of biomedical engineering, particularly in the application of electric pulses to living myocardial tissue. His innovative work aims to enhance medical treatments for heart conditions.
Latest Patents
Lilienkamp holds a patent for an "Apparatus for applying electric pulses to living myocardial tissue." This apparatus is designed to apply at least one electric pulse to living myocardial tissue. It includes an input that receives an electric signal representing the current electric activity of the myocardial tissue. The signal processor processes this electric signal to calculate a present permutation value in the state space. It only outputs a control signal when the calculated present entropy value is lower than a predetermined threshold. The pulse generator then generates the electric pulse in response to this control signal, which is subsequently output to the myocardial tissue.
Career Highlights
Lilienkamp is associated with the Max Planck Society for the Advancement of Science, where he continues to develop his innovative ideas. His work is pivotal in advancing the understanding and treatment of cardiac issues through technology.
Collaborations
He collaborates with esteemed colleagues such as Sebastian Berg and Stefan Luther, contributing to a dynamic research environment that fosters innovation.
Conclusion
Thomas Lilienkamp's contributions to the field of biomedical engineering, particularly through his patented apparatus, highlight his role as a key innovator in the application of electric pulses to myocardial tissue. His work has the potential to significantly impact medical treatments for heart conditions.